ONXEO (EPA:ALONX) | Finanzwire

Basculer en Français

10091	Companies
206598	Keywords
136782	Articles
109512	Press releases

Home
Companies
ONXEO

BRIEF

published on 05/22/2024 at 20:51, 1 year 10 months ago

Valerio Therapeutics Advances VIO-01 Clinical Trial with Positive Results

Drug Development Solid Tumors Clinical Trial Valerio Therapeutics VIO-01
PRESS RELEASE

published on 05/22/2024 at 20:46, 1 year 10 months ago

Inside Information / Other news releases
Valerio Therapeutics completes dosing for first cohort of subjects in Phase 1/2 VIO-01 trial for solid tumors, showing encouraging tolerability. Phase 1b aims to determine recommended dose in selected solid tumors

Solid Tumors Valerio Therapeutics VIO-01 Trial Phase 1/2 DNA Damage Response
BRIEF

published on 04/30/2024 at 23:19, 1 year 10 months ago

Valerio Therapeutics Reports 2023 Fiscal Year Results and Clinical Updates

Biotechnology Clinical Trials Financial Results 2023 Valerio Therapeutics VIO-01
PRESS RELEASE

published on 04/30/2024 at 23:14, 1 year 10 months ago

Annual financial and audit reports / Terms of availability of the annual financial report
Valerio Therapeutics reports full year 2023 financial results and provides clinical development updates. The company's cash position is €6.8 million as of December 31, 2023, ensuring financial visibility until Q4 2024

Financial Results Cash Position 2023 Clinical Development Valerio Therapeutics

Accesswire

Published on 03/26/2026 at 08:05, 14 minutes ago

Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 3 hours 24 minutes ago

Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 7 hours 39 minutes ago

Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 7 hours 49 minutes ago

Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 13 hours 4 minutes ago

Gemina Laboratories Ltd. Announces Delisting from the CSE

View all ACCESSWIRE

EQS Group

Published on 03/26/2026 at 08:00, 18 minutes ago

PNE AG closes the 2025 financial year with successful operational performance and focuses on core markets and profitability
Published on 03/26/2026 at 08:00, 18 minutes ago

Appointment and Retirement of Non-Executive Directors
Published on 03/26/2026 at 08:00, 18 minutes ago

CANCOM SE: CANCOM confirms preliminary figures; 2026 forecast published
Published on 03/26/2026 at 08:00, 18 minutes ago

LPKF reports slight improvement in earnings in 2025 and initiates Group realignment
Published on 03/26/2026 at 08:00, 18 minutes ago

Transaction in Own Shares

Les Echos

Published on 03/26/2026 at 07:30, 49 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:53, 13 hours 25 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 13 hours 47 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 14 hours 34 minutes ago

Combined General Meeting on May 05, 2026: publication of the notice of Meeting
Published on 03/25/2026 at 17:45, 14 hours 34 minutes ago

GUILLEMOT CORPORATION: 2025 ANNUAL RESULTS

View all LES ECHOS COMFI WIRE